Download PDF
Thromb Haemost 2022; 122(04): 529-539
DOI: 10.1055/a-1541-3706
Cellular Haemostasis and Platelets

Untargeted Plasma Metabolomics and Gut Microbiome Profiling Provide Novel Insights into the Regulation of Platelet Reactivity in Healthy Individuals

Nadira Vadaq
1   Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
2   Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands
3   Center for Tropical and Infectious Diseases, Faculty of Medicine, Diponegoro University-Dr. Kariadi Hospital, Semarang, Indonesia
,
Melanie Schirmer
4   Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States
,
Rahajeng N. Tunjungputri
1   Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
2   Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands
3   Center for Tropical and Infectious Diseases, Faculty of Medicine, Diponegoro University-Dr. Kariadi Hospital, Semarang, Indonesia
,
Hera Vlamakis
4   Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States
5   Center for Microbiome Informatics and Therapeutics, MIT, Cambridge, Massachusetts, United States
,
Cecilia Chiriac
6   National Institute of Research and Development for Biological Sciences, Institute of Biological Research, Cluj-Napoca, Romania
7   Department of Aquatic Microbial Ecology, Institute of Hydrobiology, Biology Centre of the Academy of Sciences of the Czech Republic, České Budějovice, Czech Republic
,
Edwin Ardiansyah
1   Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
2   Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands
,
M. Hussein Gasem
3   Center for Tropical and Infectious Diseases, Faculty of Medicine, Diponegoro University-Dr. Kariadi Hospital, Semarang, Indonesia
8   Department of Internal Medicine, Faculty of Medicine Diponegoro University-Dr. Kariadi Hospital, Semarang, Indonesia
,
Leo A. B. Joosten
1   Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
2   Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands
,
Philip G. de Groot
1   Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
2   Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands
,
Ramnik J. Xavier
4   Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States
5   Center for Microbiome Informatics and Therapeutics, MIT, Cambridge, Massachusetts, United States
,
Mihai G. Netea
1   Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
2   Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands
9   Department for Genomics and Immunoregulation, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany
,
Andre J. van der Ven
1   Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
2   Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands
,
Quirijn de Mast
1   Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
2   Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands
› Author Affiliations Funding N.V. was supported by the Indonesia Endowment Fund for Education (LPDP) given by the Ministry of Finance of the Republic of Indonesia. M.G. Netea was supported by an ERC Advanced Grant (833247) and a Spinoza Grant of the Netherlands Organization for Scientific Research. The Human Functional Genomics Project was supported by a European Research Council (ERC) Consolidator grant (ERC 310372). [Fig. 5] was made using Biorender (BioRender—biorender.com).
› Further Information
    Permissions and Reprints

Abstract

Background Considerable variation exists in platelet reactivity to stimulation among healthy individuals. Various metabolites and metabolic pathways influence platelet reactivity, but a comprehensive overview of these associations is missing. The gut microbiome has a strong influence on the plasma metabolome. Here, we investigated the association of platelet reactivity with results of untargeted plasma metabolomics and gut microbiome profiling.

Methods We used data from a cohort of 534 healthy adult Dutch volunteers (the 500 Functional Genomics study). Platelet activation and reactivity were measured by the expression of the alpha-granule protein P-selectin and the binding of fibrinogen to the activated integrin αIIbβ3, both in unstimulated blood and after ex vivo stimulation with platelet agonists. Plasma metabolome was measured using an untargeted metabolic profiling approach by quadrupole time-of-flight mass spectrometry. Gut microbiome data were measured by shotgun metagenomic sequencing from stool samples.

Results Untargeted metabolomics yielded 1,979 metabolites, of which 422 were identified to play a role in a human metabolic pathway. Overall, 92/422 (21.8%) metabolites were significantly associated with at least one readout of platelet reactivity. The majority of associations involved lipids, especially members of eicosanoids, including prostaglandins and leukotrienes. Dietary-derived polyphenols were also found to inhibit platelet reactivity. Validation of metabolic pathways with functional microbial profiles revealed two overlapping metabolic pathways (“alanine, aspartate, and glutamate metabolism” and “arginine biosynthesis”) that were associated with platelet reactivity.

Conclusion This comprehensive overview is an resource for understanding the regulation of platelet reactivity by the plasma metabolome and the possible contribution of the gut microbiota.

Keywords

metabolome - microbiome - platelet - platelet reactivity

Supplementary Material



Publication History

Received: 18 January 2021

Accepted: 28 June 2021

Accepted Manuscript online:
30 June 2021

Article published online:
13 August 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Franco AT, Corken A, Ware J. Platelets at the interface of thrombosis, inflammation, and cancer. Blood 2015; 126 (05) 582-588
    CrossrefPubMedGoogle Scholar
  • 2 Lindkvist M, Fernberg U, Ljungberg LU. et al. Individual variations in platelet reactivity towards ADP, epinephrine, collagen and nitric oxide, and the association to arterial function in young, healthy adults. Thromb Res 2019; 174: 5-12
    CrossrefPubMedGoogle Scholar
  • 3 Puurunen MK, Hwang SJ, Larson MG. et al. ADP platelet hyperreactivity predicts cardiovascular disease in the FHS (Framingham Heart Study). J Am Heart Assoc 2018; 7 (05) e008522
    CrossrefPubMedGoogle Scholar
  • 4 Jones CI, Bray S, Garner SF. et al; Bloodomics Consortium. A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways. Blood 2009; 114 (07) 1405-1416
    CrossrefPubMedGoogle Scholar
  • 5 Johnson AD, Yanek LR, Chen MH. et al. Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nat Genet 2010; 42 (07) 608-613
    CrossrefPubMedGoogle Scholar
  • 6 Miller CH, Rice AS, Garrett K, Stein SF. Gender, race and diet affect platelet function tests in normal subjects, contributing to a high rate of abnormal results. Br J Haematol 2014; 165 (06) 842-853
    CrossrefPubMedGoogle Scholar
  • 7 Yeung J, Hawley M, Holinstat M. The expansive role of oxylipins on platelet biology. J Mol Med (Berl) 2017; 95 (06) 575-588
    CrossrefPubMedGoogle Scholar
  • 8 Vallance TM, Ravishankar D, Albadawi DAI, Osborn HMI, Vaiyapuri S. Synthetic flavonoids as novel modulators of platelet function and thrombosis. Int J Mol Sci 2019; 20 (12) E3106
    CrossrefPubMedGoogle Scholar
  • 9 Roşca AE, Vlădăreanu AM, Mititelu A. et al. Effects of exogenous androgens on platelet activity and their thrombogenic potential in supraphysiological administration: a literature review. J Clin Med 2021; 10 (01) E147
    CrossrefPubMedGoogle Scholar
  • 10 Nicholson G, Rantalainen M, Maher AD. et al; The Molpage Consortium. Human metabolic profiles are stably controlled by genetic and environmental variation. Mol Syst Biol 2011; 7: 525
    CrossrefPubMedGoogle Scholar
  • 11 Sridharan GV, Choi K, Klemashevich C. et al. Prediction and quantification of bioactive microbiota metabolites in the mouse gut. Nat Commun 2014; 5: 5492
    CrossrefPubMedGoogle Scholar
  • 12 Wilmanski T, Rappaport N, Earls JC. et al. Blood metabolome predicts gut microbiome α-diversity in humans. Nat Biotechnol 2019; 37 (10) 1217-1228
    CrossrefPubMedGoogle Scholar
  • 13 Ter Horst R, Jaeger M, Smeekens SP. et al. Host and environmental factors influencing individual human cytokine responses. Cell 2016; 167 (04) 1111.e13-1124.e13
    CrossrefPubMedGoogle Scholar
  • 14 Tunjungputri RN, Li Y, de Groot PG. et al. The inter-relationship of platelets with interleukin-1β-mediated inflammation in humans. Thromb Haemost 2018; 118 (12) 2112-2125
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Feist AM, Henry CS, Reed JL. et al. A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information. Mol Syst Biol 2007; 3: 121
    CrossrefPubMedGoogle Scholar
  • 16 Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 2017; 45 (D1): D353-D361
    CrossrefPubMedGoogle Scholar
  • 17 Schirmer M, Smeekens SP, Vlamakis H. et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell 2016; 167 (04) 1125-1136
    CrossrefPubMedGoogle Scholar
  • 18 Chong J, Soufan O, Li C. et al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res 2018; 46 (W1): W486-W494
    CrossrefPubMedGoogle Scholar
  • 19 Stevens VL, Hoover E, Wang Y, Zanetti KA. Pre-analytical factors that affect metabolite stability in human urine, plasma, and serum: a review. Metabolites 2019; 9 (08) E156
    CrossrefPubMedGoogle Scholar
  • 20 Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004; 79 (05) 727-747
    CrossrefPubMedGoogle Scholar
  • 21 Iyú D, Glenn JR, White AE, Johnson AJ, Fox SC, Heptinstall S. The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet function. Platelets 2010; 21 (05) 329-342
    CrossrefPubMedGoogle Scholar
  • 22 Kashiwagi H, Yuhki KI, Imamichi Y. et al. Prostaglandin F2α facilitates platelet activation by acting on prostaglandin E2 receptor subtype EP3 and thromboxane A2 receptor TP in mice. Thromb Haemost 2019; 119 (08) 1311-1320
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Rybicki JP, Le Breton GC. Prostaglandin H2 directly lowers human platelet cAMP levels. Thromb Res 1983; 30 (05) 407-414
    CrossrefPubMedGoogle Scholar
  • 24 Setty BN, Werner MH, Hannun YA, Stuart MJ. 15-Hydroxyeicosatetraenoic acid-mediated potentiation of thrombin-induced platelet functions occurs via enhanced production of phosphoinositide-derived second messengers–sn-1,2-diacylglycerol and inositol-1,4,5-trisphosphate. Blood 1992; 80 (11) 2765-2773
    CrossrefPubMedGoogle Scholar
  • 25 Diehl P, Nienaber F, Zaldivia MTK. et al. Lysophosphatidylcholine is a major component of platelet microvesicles promoting platelet activation and reporting atherosclerotic plaque instability. Thromb Haemost 2019; 119 (08) 1295-1310
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Haserück N, Erl W, Pandey D. et al. The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors. Blood 2004; 103 (07) 2585-2592
    CrossrefPubMedGoogle Scholar
  • 27 Kudo I, Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat 2002; 68–69: 3-58
    CrossrefPubMedGoogle Scholar
  • 28 Liu M, Wallmon A, Olsson-Mortlock C, Wallin R, Saldeen T. Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. Am J Clin Nutr 2003; 77 (03) 700-706
    CrossrefPubMedGoogle Scholar
  • 29 Freedman JE, Keaney Jr JF. Vitamin E inhibition of platelet aggregation is independent of antioxidant activity. J Nutr 2001; 131 (02) 374S-377S
    CrossrefPubMedGoogle Scholar
  • 30 Jing L, Yanyan Z, Junfeng F. Acetic acid in aged vinegar affects molecular targets for thrombus disease management. Food Funct 2015; 6 (08) 2845-2853
    CrossrefPubMedGoogle Scholar
  • 31 Al-Shiblawi NK. Role of Kynurenine on Platelet's Function and Beyond. Dublin: Trinity College Dublin; School of Pharmacy & Pharmaceutical Sciences; 2020
    Google Scholar
  • 32 Aibibula M, Naseem KM, Sturmey RG. Glucose metabolism and metabolic flexibility in blood platelets. J Thromb Haemost 2018; 16 (11) 2300-2314
    CrossrefPubMedGoogle Scholar
  • 33 Högberg C, Gidlöf O, Tan C. et al. Succinate independently stimulates full platelet activation via cAMP and phosphoinositide 3-kinase-β signaling. J Thromb Haemost 2011; 9 (02) 361-372
    CrossrefPubMedGoogle Scholar
  • 34 Bertoni A, Rastoldo A, Sarasso C. et al. Dehydroepiandrosterone-sulfate inhibits thrombin-induced platelet aggregation. Steroids 2012; 77 (03) 260-268
    CrossrefPubMedGoogle Scholar
  • 35 Banerjee D, Mazumder S, Bhattacharya S, Sinha AK. The sex specific effects of extraneous testosterone on ADP induced platelet aggregation in platelet-rich plasma from male and female subjects. Int J Lab Hematol 2014; 36 (05) e74-e77
    CrossrefPubMedGoogle Scholar
  • 36 Patneau DK, Mayer ML. Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors. J Neurosci 1990; 10 (07) 2385-2399
    CrossrefPubMedGoogle Scholar
  • 37 Green TN, Hamilton JR, Morel-Kopp MC. et al. Inhibition of NMDA receptor function with an anti-GluN1-S2 antibody impairs human platelet function and thrombosis. Platelets 2017; 28 (08) 799-811
    CrossrefPubMedGoogle Scholar
  • 38 Mauri MC, Ferrara A, Boscati L. et al. Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment. Neuropsychobiology 1998; 37 (03) 124-129
    CrossrefPubMedGoogle Scholar
  • 39 Summar ML, Gainer JV, Pretorius M. et al. Relationship between carbamoyl-phosphate synthetase genotype and systemic vascular function. Hypertension 2004; 43 (02) 186-191
    CrossrefPubMedGoogle Scholar
  • 40 Liu Y, Hou Y, Wang G, Zheng X, Hao H. Gut microbial metabolites of aromatic amino acids as signals in host-microbe interplay. Trends Endocrinol Metab 2020; 31 (11) 818-834
    CrossrefPubMedGoogle Scholar
  • 41 Newsome SD, Feeser KL, Bradley CJ, Wolf C, Takacs-Vesbach C, Fogel ML. Isotopic and genetic methods reveal the role of the gut microbiome in mammalian host essential amino acid metabolism. Proc Biol Sci 2020; 287 (1922): 20192995
    PubMedGoogle Scholar
  • 42 Woodmansey EJ, McMurdo ME, Macfarlane GT, Macfarlane S. Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 2004; 70 (10) 6113-6122
    CrossrefPubMedGoogle Scholar
  • 43 Pell VR, Spiroski A-M, Mulvey J. et al. Ischemic preconditioning protects against cardiac ischemia reperfusion injury without affecting succinate accumulation or oxidation. J Mol Cell Cardiol 2018; 123: 88-91
    CrossrefPubMedGoogle Scholar
  • 44 Strandwitz P, Kim KH, Terekhova D. et al. GABA-modulating bacteria of the human gut microbiota. Nat Microbiol 2019; 4 (03) 396-403
    CrossrefPubMedGoogle Scholar
  • 45 Rainesalo S, Keränen T, Saransaari P, Honkaniemi J. GABA and glutamate transporters are expressed in human platelets. Brain Res Mol Brain Res 2005; 141 (02) 161-165
    CrossrefPubMedGoogle Scholar
  • 46 Lin KH, Lu WJ, Wang SH. et al. Characteristics of endogenous γ-aminobutyric acid (GABA) in human platelets: functional studies of a novel collagen glycoprotein VI inhibitor. J Mol Med (Berl) 2014; 92 (06) 603-614
    CrossrefPubMedGoogle Scholar
  • 47 Zhu W, Gregory JC, Org E. et al. Gut Microbial Metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 2016; 165 (01) 111-124
    CrossrefPubMedGoogle Scholar
  • 48 Nemet I, Saha PP, Gupta N. et al. A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors. Cell 2020; 180 (05) 862.e22-877.e22
    CrossrefPubMedGoogle Scholar